Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model of Sanfilippo syndrome type B - PubMed (original) (raw)
. 2001 Jun 15;74(3):299-305.
doi: 10.1006/geno.2001.6552.
Affiliations
- PMID: 11414757
- DOI: 10.1006/geno.2001.6552
Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model of Sanfilippo syndrome type B
E L Aronovich et al. Genomics. 2001.
Abstract
Sanfilippo syndrome type B, or mucopolysaccharidosis (MPS) IIIB, is an autosomal recessive disease caused by a deficiency of lysosomal alpha-N-acetylglucosaminidase (NAGLU). In Dromaius novaehollandiae (emu), a progressive neurologic disease was recently discovered, which was characterized by NAGLU deficiency and heparan sulfate accumulation. To define the molecular basis, the sequences of the normal emu NAGLU cDNA and gene were determined by PCR-based approaches using primers for highly conserved regions of evolutionarily distant NAGLU homologues. It was observed that the emu NAGLU gene is structurally similar to that of human and mouse, but the introns are considerably shorter. The cDNA had an open reading frame (ORF) of 2259 bp. The deduced amino acid sequence is estimated to share 64% identity with human, 63% with mouse, 41% with Drosophila, 39% with tobacco, and 35% with the Caenorhabditis elegans enzyme. Three normal and two affected emus were studied for nucleotide sequence covering the entire coding region and exon-intron boundaries. Unlike the human gene, emu NAGLU appeared to be highly polymorphic: 19 variations were found in the coding region alone. The two affected emus were found to be homozygous for a 2-bp deletion, 1098-1099delGG, in exon 6. The resulting frameshift predicts a longer ORF of 2370 bp encoding a polypeptide with 37 additional amino acids and 387 altered amino acids. The availability of mutation screening in emus now permits early detection of MPS IIIB in breeding stocks and is an important step in characterizing this unique, naturally occurring avian model for the development of gene transfer studies.
Copyright 2001 Academic Press.
Similar articles
- Mucopolysaccharidosis IIIB (Sanfilippo syndrome B) in a commercial emu (Dromaius novaehollandiae) flock.
Genger SC, Mizukami K, Martin MP, Applegate JR Jr, Barnes HJ, Giger U. Genger SC, et al. Avian Pathol. 2018 Feb;47(1):100-107. doi: 10.1080/03079457.2017.1380293. Epub 2017 Oct 10. Avian Pathol. 2018. PMID: 28911234 Free PMC article. - Canine heparan sulfate sulfamidase and the molecular pathology underlying Sanfilippo syndrome type A in Dachshunds.
Aronovich EL, Carmichael KP, Morizono H, Koutlas IG, Deanching M, Hoganson G, Fischer A, Whitley CB. Aronovich EL, et al. Genomics. 2000 Aug 15;68(1):80-4. doi: 10.1006/geno.2000.6275. Genomics. 2000. PMID: 10950929 - Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain.
Gografe SI, Garbuzova-Davis S, Willing AE, Haas K, Chamizo W, Sanberg PR. Gografe SI, et al. Comp Med. 2003 Dec;53(6):622-32. Comp Med. 2003. PMID: 14727810 - Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
Yogalingam G, Hopwood JJ. Yogalingam G, et al. Hum Mutat. 2001 Oct;18(4):264-81. doi: 10.1002/humu.1189. Hum Mutat. 2001. PMID: 11668611 Review. - Sanfilippo syndrome type C: mutation spectrum in the heparan sulfate acetyl-CoA: alpha-glucosaminide N-acetyltransferase (HGSNAT) gene.
Feldhammer M, Durand S, Mrázová L, Boucher RM, Laframboise R, Steinfeld R, Wraith JE, Michelakakis H, van Diggelen OP, Hrebícek M, Kmoch S, Pshezhetsky AV. Feldhammer M, et al. Hum Mutat. 2009 Jun;30(6):918-25. doi: 10.1002/humu.20986. Hum Mutat. 2009. PMID: 19479962 Review.
Cited by
- Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model.
Martins C, Hůlková H, Dridi L, Dormoy-Raclet V, Grigoryeva L, Choi Y, Langford-Smith A, Wilkinson FL, Ohmi K, DiCristo G, Hamel E, Ausseil J, Cheillan D, Moreau A, Svobodová E, Hájková Z, Tesařová M, Hansíková H, Bigger BW, Hrebícek M, Pshezhetsky AV. Martins C, et al. Brain. 2015 Feb;138(Pt 2):336-55. doi: 10.1093/brain/awu355. Epub 2015 Jan 6. Brain. 2015. PMID: 25567323 Free PMC article. - A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs.
Ellinwood NM, Wang P, Skeen T, Sharp NJ, Cesta M, Decker S, Edwards NJ, Bublot I, Thompson JN, Bush W, Hardam E, Haskins ME, Giger U. Ellinwood NM, et al. J Inherit Metab Dis. 2003;26(5):489-504. doi: 10.1023/a:1025177411938. J Inherit Metab Dis. 2003. PMID: 14518829 - Mucopolysaccharidosis IIIB (Sanfilippo syndrome B) in a commercial emu (Dromaius novaehollandiae) flock.
Genger SC, Mizukami K, Martin MP, Applegate JR Jr, Barnes HJ, Giger U. Genger SC, et al. Avian Pathol. 2018 Feb;47(1):100-107. doi: 10.1080/03079457.2017.1380293. Epub 2017 Oct 10. Avian Pathol. 2018. PMID: 28911234 Free PMC article. - Exploiting the Potential of Drosophila Models in Lysosomal Storage Disorders: Pathological Mechanisms and Drug Discovery.
Rigon L, De Filippis C, Napoli B, Tomanin R, Orso G. Rigon L, et al. Biomedicines. 2021 Mar 7;9(3):268. doi: 10.3390/biomedicines9030268. Biomedicines. 2021. PMID: 33800050 Free PMC article. Review. - Bovine mucopolysaccharidosis type IIIB.
Karageorgos L, Hill B, Bawden MJ, Hopwood JJ. Karageorgos L, et al. J Inherit Metab Dis. 2007 Jun;30(3):358-64. doi: 10.1007/s10545-007-0539-5. Epub 2007 Apr 24. J Inherit Metab Dis. 2007. PMID: 17458708